Privacy Policy
This page is a working draft. Subreal Limited (company no. 15590312, registered in England & Wales) is the data controller for information collected through this website and through participation in our research and clinical-software programmes.
1 · What we collect
Website. We collect minimal analytics — page views, referrers and aggregated device information — to understand how visitors discover Subreal. We do not use advertising trackers.
Correspondence. When you email us, your name, email address and message content are processed so we can reply and, where relevant, evaluate collaboration or investment opportunities.
Research participants. Personal data collected inside Subreal-CARE or through partnered studies is governed by study-specific information sheets and ethics approvals — not by this page.
2 · Legal basis (UK GDPR)
We rely on legitimate interests for general correspondence and website analytics, contractual necessity for commercial and research agreements, and explicit consent for any clinical data handled inside Subreal-CARE.
3 · Sharing & processors
We use a small number of vetted processors (hosting, email, analytics). Each is bound by a data-processing agreement and stores data within the UK, EEA or jurisdictions with adequate protections. We do not sell personal data.
4 · Retention
Correspondence is retained for as long as a relationship is active, then archived for a further 24 months. Website analytics are aggregated and retained for 14 months. Clinical data follows the retention schedule of the relevant study protocol.
5 · Your rights
You have the right to access, rectify, erase or port your personal data, and to object to or restrict its processing. Requests should be sent to michal.bartler@subreal.io. You may also complain to the UK Information Commissioner’s Office.
6 · Contact
Subreal Limited, 7 Bell Yard, London WC2A 2JR, United Kingdom. Email michal.bartler@subreal.io.
This draft is a starting point only and does not yet constitute finalised legal advice. A full version will replace it before Subreal-CARE leaves investigational status.